Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity

November 2023 | 211 pages | ID: GF2C9265087EEN
GMD Research

Abstracts

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as COVID-19 vaccines, and the increasing healthcare expenditure.

Highlighted with 111 tables and 87 figures, this 211-page report “Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global preventive vaccines market in every aspect of the classification from perspectives of Vaccine Type, Disease, Administration, Patient, and Region.

Based on Vaccine Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Live/Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Conjugate Vaccines
• mRNA Vaccines
• Recombinant Vector Vaccines
• Other Vaccines

Based on Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Pneumococcal Disease
• Poliovirus
• Hepatitis
• Influenza
• Measles, Mumps, and Rubella (MMR)
• Varicella
• Human Papilloma Virus
• COVID-19
• Other Diseases

By Administration, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Intramuscular Route
• Subcutaneous Route
• Oral Route
• Intravenous Injection
• Other Administration Routes

By Patient, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Pediatric Vaccines
• Pneumococcal
• Measles, Mumps, and Rubella (MMR)
• Varicella
• Hepatitis
• Poliovirus
• Haemophilus Influenzae B (HIB)
• Other Diseases
• Adult Vaccines
• Influenza
• Cervical Cancer
• Hepatitis
• Zoster
• Other Diseases

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)

For each region and country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and the breakdown of each national market by Vaccine Type, Disease, and Administration over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

AstraZeneca plc

Bavarian Nordic A/S

China National Biotec Group Company Ltd.

CSL Ltd.

Daiichi Sankyo Co. Ltd

Emergent BioSolutions Inc.

GlaxoSmithKline plc

Johnson & Johnson

Merck & Co.

Moderna Inc.

Novavax, Inc.

Pfizer Inc.

Sanofi SA

Takeda Pharmaceutical Co. Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
  2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY VACCINE TYPE

3.1 Market Overview by Vaccine Type
3.2 Live/Attenuated Vaccines
3.3 Inactivated Vaccines
3.4 Subunit Vaccines
3.5 Toxoid Vaccines
3.6 Conjugate Vaccines
3.7 mRNA Vaccines
3.8 Recombinant Vector Vaccines
3.9 Other Vaccines

4 SEGMENTATION OF GLOBAL MARKET BY DISEASE

4.1 Market Overview by Disease
4.2 Pneumococcal Disease
4.3 Poliovirus
4.4 Hepatitis
4.5 Influenza
4.6 Measles, Mumps, and Rubella (MMR)
4.7 Varicella
4.8 Human Papilloma Virus
4.9 COVID-19
4.10 Other Diseases

5 SEGMENTATION OF GLOBAL MARKET BY ADMINISTRATION

5.1 Market Overview by Administration
5.2 Intramuscular Route
5.3 Subcutaneous Route
5.4 Oral Route
5.5 Intravenous Injection
5.6 Other Administration Routes

6 SEGMENTATION OF GLOBAL MARKET BY PATIENT

6.1 Market Overview by Patient
6.2 Pediatric Vaccines
6.3 Adult Vaccines

7 SEGMENTATION OF GLOBAL MARKET BY REGION

7.1 Geographic Market Overview 2022-2032
7.2 North America Market 2022-2032 by Country
  7.2.1 Overview of North America Market
  7.2.2 U.S.
  7.2.3 Canada
  7.2.4 Mexico
7.3 European Market 2022-2032 by Country
  7.3.1 Overview of European Market
  7.3.2 Germany
  7.3.3 U.K.
  7.3.4 France
  7.3.5 Spain
  7.3.6 Italy
  7.3.7 Russia
  7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2022-2032 by Country
  7.4.1 Overview of Asia-Pacific Market
  7.4.2 Japan
  7.4.3 China
  7.4.4 Australia
  7.4.5 India
  7.4.6 South Korea
  7.4.7 Rest of APAC Region
7.5 South America Market 2022-2032 by Country
  7.5.1 Argentina
  7.5.2 Brazil
  7.5.3 Chile
  7.5.4 Rest of South America Market
7.6 MEA Market 2022-2032 by Country
  7.6.1 UAE
  7.6.2 Saudi Arabia
  7.6.3 South Africa
  7.6.4 Other National Markets

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
AstraZeneca plc
Bavarian Nordic A/S
China National Biotec Group Company Ltd.
CSL Ltd.
Daiichi Sankyo Co. Ltd
Emergent BioSolutions Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co.
Moderna Inc.
Novavax, Inc.
Pfizer Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Preventive Vaccines Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. Main Product Trends and Market Opportunities in Global Preventive Vaccines Market
Table 7. Global Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 8. Global Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 9. Global Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 10. Global Preventive Vaccines Market by Patient, 2022-2032, $ mn
Table 11. Global Preventive Vaccines Market: Pediatric Vaccines by Disease, 2022-2032, $ mn
Table 12. Global Preventive Vaccines Market: Adult Vaccines by Disease, 2022-2032, $ mn
Table 13. Global Preventive Vaccines Market by Region, 2022-2032, $ mn
Table 14. Leading National Preventive Vaccines Market, 2022 and 2032, $ mn
Table 15. North America Preventive Vaccines Market by Country, 2022-2032, $ mn
Table 16. U.S. Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 17. U.S. Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 18. U.S. Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 19. Canada Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 20. Canada Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 21. Canada Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 22. Mexico Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 23. Mexico Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 24. Mexico Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 25. Europe Preventive Vaccines Market by Country, 2022-2032, $ mn
Table 26. Germany Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 27. Germany Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 28. Germany Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 29. U.K. Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 30. U.K. Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 31. U.K. Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 32. France Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 33. France Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 34. France Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 35. Spain Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 36. Spain Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 37. Spain Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 38. Italy Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 39. Italy Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 40. Italy Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 41. Russia Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 42. Russia Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 43. Russia Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 44. Preventive Vaccines Market in Rest of Europe by Country, 2022-2032, $ mn
Table 45. APAC Preventive Vaccines Market by Country, 2022-2032, $ mn
Table 46. Japan Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 47. Japan Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 48. Japan Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 49. China Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 50. China Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 51. China Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 52. Australia Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 53. Australia Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 54. Australia Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 55. India Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 56. India Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 57. India Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 58. South Korea Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 59. South Korea Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 60. South Korea Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 61. Preventive Vaccines Market in Rest of APAC by Country/Region, 2022-2032, $ mn
Table 62. South America Preventive Vaccines Market by Country, 2022-2032, $ mn
Table 63. Argentina Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 64. Argentina Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 65. Argentina Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 66. Brazil Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 67. Brazil Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 68. Brazil Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 69. Chile Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 70. Chile Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 71. Chile Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 72. MEA Preventive Vaccines Market by Country, 2022-2032, $ mn
Table 73. UAE Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 74. UAE Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 75. UAE Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 76. Saudi Arabia Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 77. Saudi Arabia Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 78. Saudi Arabia Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 79. South Africa Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn
Table 80. South Africa Preventive Vaccines Market by Disease, 2022-2032, $ mn
Table 81. South Africa Preventive Vaccines Market by Administration, 2022-2032, $ mn
Table 82. AstraZeneca plc: Company Snapshot
Table 83. AstraZeneca plc: Business Segmentation
Table 84. AstraZeneca plc: Product Portfolio
Table 85. Bavarian Nordic A/S: Company Snapshot
Table 86. Bavarian Nordic A/S: Marketed Products and Pipeline, as of July 2020
Table 87. China National Biotec Group Company Ltd.: Company Snapshot
Table 88. CSL Ltd.: Company Snapshot
Table 89. Daiichi Sankyo Co. Ltd.: Company Snapshot
Table 90. Emergent BioSolutions Inc.: Company Snapshot
Table 91. GlaxoSmithKline: Company Snapshot
Table 92. GlaxoSmithKline: Business Segmentation
Table 93. GlaxoSmithKline: Product Portfolio
Table 94. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 95. GlaxoSmithKline: Recent Developments
Table 96. Johnson & Johnson: Company Snapshot
Table 97. Johnson & Johnson: Business Segments
Table 98. Merck & Co., Inc.: Company Snapshot
Table 99. Merck & Co., Inc.: Business Segmentation
Table 100. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 101. Moderna Inc.: Company Snapshot
Table 102. Novavax, Inc.: Company Snapshot
Table 103. Pfizer Inc.: Company Snapshot
Table 104. Pfizer Inc.: Business Segmentation
Table 105. Pfizer Inc.: Product Portfolio
Table 106. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 107. Pfizer Inc.: Recent Developments
Table 108. Sanofi: Company Snapshot
Table 109. Sanofi: Business Segmentation
Table 110. Sanofi: Revenue, 2018-2020, $ bn
Table 111. Takeda Pharmaceutical Co. Ltd.: Company Snapshot

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Global Preventive Vaccines Market, 2022-2032, $ mn
Figure 5. Development Stages of Preventive Vaccines
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Preventive Vaccines Market
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Global Preventive Vaccines Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Global Preventive Vaccines Market
Figure 14. Breakdown of Global Preventive Vaccines Market by Vaccine Type, 2022-2032, % of Revenue
Figure 15. Global Addressable Market Cap in 2023-2032 by Vaccine Type, Value ($ mn) and Share (%)
Figure 16. Global Preventive Vaccines Market by Vaccine Type: Live/Attenuated Vaccines, 2022-2032, $ mn
Figure 17. Global Preventive Vaccines Market by Vaccine Type: Inactivated Vaccines, 2022-2032, $ mn
Figure 18. Global Preventive Vaccines Market by Vaccine Type: Subunit Vaccines, 2022-2032, $ mn
Figure 19. Global Preventive Vaccines Market by Vaccine Type: Toxoid Vaccines, 2022-2032, $ mn
Figure 20. Global Preventive Vaccines Market by Vaccine Type: Conjugate Vaccines, 2022-2032, $ mn
Figure 21. Global Preventive Vaccines Market by Vaccine Type: mRNA Vaccines, 2022-2032, $ mn
Figure 22. Global Preventive Vaccines Market by Vaccine Type: Recombinant Vector Vaccines, 2022-2032, $ mn
Figure 23. Global Preventive Vaccines Market by Vaccine Type: Other Vaccines, 2022-2032, $ mn
Figure 24. Breakdown of Global Preventive Vaccines Market by Disease, 2022-2032, % of Sales Revenue
Figure 25. Global Addressable Market Cap in 2023-2032 by Disease, Value ($ mn) and Share (%)
Figure 26. Global Preventive Vaccines Market by Disease: Pneumococcal Disease, 2022-2032, $ mn
Figure 27. Global Preventive Vaccines Market by Disease: Poliovirus, 2022-2032, $ mn
Figure 28. Global Preventive Vaccines Market by Disease: Hepatitis, 2022-2032, $ mn
Figure 29. Global Preventive Vaccines Market by Disease: Influenza, 2022-2032, $ mn
Figure 30. Global Preventive Vaccines Market by Disease: Measles, Mumps, and Rubella (MMR), 2022-2032, $ mn
Figure 31. Global Preventive Vaccines Market by Disease: Varicella, 2022-2032, $ mn
Figure 32. Global Preventive Vaccines Market by Disease: Human Papilloma Virus, 2022-2032, $ mn
Figure 33. Global Preventive Vaccines Market by Disease: COVID-19, 2022-2032, $ mn
Figure 34. Global Preventive Vaccines Market by Disease: Other Diseases, 2022-2032, $ mn
Figure 35. Breakdown of Global Preventive Vaccines Market by Administration, 2022-2032, % of Sales Revenue
Figure 36. Global Addressable Market Cap in 2023-2032 by Administration, Value ($ mn) and Share (%)
Figure 37. Global Preventive Vaccines Market by Administration: Intramuscular Route, 2022-2032, $ mn
Figure 38. Global Preventive Vaccines Market by Administration: Subcutaneous Route, 2022-2032, $ mn
Figure 39. Global Preventive Vaccines Market by Administration: Oral Route, 2022-2032, $ mn
Figure 40. Global Preventive Vaccines Market by Administration: Intravenous Injection, 2022-2032, $ mn
Figure 41. Global Preventive Vaccines Market by Administration: Other Administration Routes, 2022-2032, $ mn
Figure 42. Breakdown of Global Preventive Vaccines Market by Patient, 2022-2032, % of Revenue
Figure 43. Global Addressable Market Cap in 2023-2032 by Patient, Value ($ mn) and Share (%)
Figure 44. Global Preventive Vaccines Market by Patient: Pediatric Vaccines, 2022-2032, $ mn
Figure 45. Global Preventive Vaccines Market by Patient: Adult Vaccines, 2022-2032, $ mn
Figure 46. Global Market Snapshot by Region
Figure 47. Geographic Spread of Worldwide Preventive Vaccines Market, 2022-2032, % of Sales Revenue
Figure 48. Global Addressable Market Cap in 2023-2032 by Region, Value ($ mn) and Share (%)
Figure 49. North American Preventive Vaccines Market, 2022-2032, $ mn
Figure 50. Breakdown of North America Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue
Figure 51. Contribution to North America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 52. U.S. Preventive Vaccines Market, 2022-2032, $ mn
Figure 53. Canada Preventive Vaccines Market, 2022-2032, $ mn
Figure 54. Preventive Vaccines Market in Mexico, 2022-2032, $ mn
Figure 55. European Preventive Vaccines Market, 2022-2032, $ mn
Figure 56. Breakdown of European Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue
Figure 57. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 58. Preventive Vaccines Market in Germany, 2022-2032, $ mn
Figure 59. Preventive Vaccines Market in U.K., 2022-2032, $ mn
Figure 60. Preventive Vaccines Market in France, 2022-2032, $ mn
Figure 61. Preventive Vaccines Market in Spain, 2022-2032, $ mn
Figure 62. Preventive Vaccines Market in Italy, 2022-2032, $ mn
Figure 63. Preventive Vaccines Market in Russia, 2022-2032, $ mn
Figure 64. Preventive Vaccines Market in Rest of Europe, 2022-2032, $ mn
Figure 65. Asia-Pacific Preventive Vaccines Market, 2022-2032, $ mn
Figure 66. Breakdown of APAC Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue
Figure 67. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 68. Preventive Vaccines Market in Japan, 2022-2032, $ mn
Figure 69. Preventive Vaccines Market in China, 2022-2032, $ mn
Figure 70. Preventive Vaccines Market in Australia, 2022-2032, $ mn
Figure 71. Preventive Vaccines Market in India, 2022-2032, $ mn
Figure 72. Preventive Vaccines Market in South Korea, 2022-2032, $ mn
Figure 73. Preventive Vaccines Market in Rest of APAC, 2022-2032, $ mn
Figure 74. South America Preventive Vaccines Market, 2022-2032, $ mn
Figure 75. Breakdown of South America Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue
Figure 76. Contribution to South America 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 77. Preventive Vaccines Market in Argentina, 2022-2032, $ mn
Figure 78. Preventive Vaccines Market in Brazil, 2022-2032, $ mn
Figure 79. Preventive Vaccines Market in Chile, 2022-2032, $ mn
Figure 80. Preventive Vaccines Market in Rest of South America, 2022-2032, $ mn
Figure 81. Preventive Vaccines Market in Middle East and Africa (MEA), 2022-2032, $ mn
Figure 82. Breakdown of MEA Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue
Figure 83. Contribution to MEA 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 84. Preventive Vaccines Market in UAE, 2022-2032, $ mn
Figure 85. Preventive Vaccines Market in Saudi Arabia, 2022-2032, $ mn
Figure 86. Preventive Vaccines Market in South Africa, 2022-2032, $ mn
Figure 87. Growth Stage of Global Preventive Vaccines Industry over the Forecast Period